Astegolimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6524]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Benralizumab to reduce exacerbations in moderate to very severe chronic obstructive pulmonary disease [ID1394]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC